500 related articles for article (PubMed ID: 12457374)
1. Pharmacotherapy of anxious disorders.
Bourin M; Lambert O
Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
[TBL] [Abstract][Full Text] [Related]
2. Let's talk facts about anxiety disorders.
American Psychiatric Association
J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997
[No Abstract] [Full Text] [Related]
3. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
Donovan MR; Glue P; Kolluri S; Emir B
J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
[TBL] [Abstract][Full Text] [Related]
4. Anxious depression.
Lydiard RB; Brawman-Mintzer O
J Clin Psychiatry; 1998; 59 Suppl 18():10-7. PubMed ID: 9840193
[TBL] [Abstract][Full Text] [Related]
5. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
6. The pharmacologic treatment of anxiety disorders: a review of progress.
Ravindran LN; Stein MB
J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
[TBL] [Abstract][Full Text] [Related]
7. Patient information. Anxiety disorders.
Adv Nurse Pract; 2003 Mar; 11(3):41. PubMed ID: 12683168
[No Abstract] [Full Text] [Related]
8. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
Brady KT; Verduin ML
Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
[TBL] [Abstract][Full Text] [Related]
9. Chronic anxiety: deciding the length of treatment.
Gorman JM; Papp LA
J Clin Psychiatry; 1990 Jan; 51 Suppl():11-5. PubMed ID: 1967247
[TBL] [Abstract][Full Text] [Related]
10. Anxiety disorders in schizophrenia.
Braga RJ; Petrides G; Figueira I
Compr Psychiatry; 2004; 45(6):460-8. PubMed ID: 15526257
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the understanding and treatment of anxiety disorders.
Shearer SL
Prim Care; 2007 Sep; 34(3):475-504, v-vi. PubMed ID: 17868756
[TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
[TBL] [Abstract][Full Text] [Related]
14. The assessment and treatment of refractory anxiety.
Hollander E; Cohen LJ
J Clin Psychiatry; 1994 Feb; 55 Suppl():27-31. PubMed ID: 7915712
[TBL] [Abstract][Full Text] [Related]
15. Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescents.
Hammerness P; Harpold T; Petty C; Menard C; Zar-Kessler C; Biederman J
J Affect Disord; 2008 Jan; 105(1-3):213-9. PubMed ID: 17572506
[TBL] [Abstract][Full Text] [Related]
16. Behavioral psychotherapy for anxiety disorders.
Marks I
Psychiatr Clin North Am; 1985 Mar; 8(1):25-35. PubMed ID: 2859579
[TBL] [Abstract][Full Text] [Related]
17. An overview of anxiety disorders.
Pasnau RO; Bystritsky A
Bull Menninger Clin; 1990; 54(2):157-70. PubMed ID: 2194605
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anxiety disorders to remission.
Ballenger JC
J Clin Psychiatry; 2001; 62 Suppl 12():5-9. PubMed ID: 11430617
[TBL] [Abstract][Full Text] [Related]
19. [Adjustment disorders and anxiety disorders].
Gohier B; Chocard AS; Duverger P; Garré JB
Rev Prat; 2007 Nov; 57(18):2061-6. PubMed ID: 18326442
[No Abstract] [Full Text] [Related]
20. Progress in psychosocial assessment and treatment.
Feske U; Shear MK
Depress Anxiety; 1999; 9(1):32-43. PubMed ID: 9989348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
